Showing results (501-510 of 515) with videos related to
Sort By:
Pageof 52
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|December 27, 2018
[Thoughts and principles of diagnosis and treatment of chronic refractory wounds in China]W Dong, Y R Xiao, M J Wu, et al.Genes & Development|April 24, 1999
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingM A Lomaga, W C Yeh, I Sarosi, et al.Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.Zhonghua Yi Xue Za Zhi|July 24, 2023
[Survey of Helicobacter pylori levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]L M Du, S J Hu, X M Chen, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 21, 2021
[Clinical features and treatment outcome of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract]Y T Zhao, Y Wang, S N Qi, et al.Zhonghua Yi Xue Za Zhi|December 6, 2021
[The effects of sequence of radiotherapy and chemotherapy on prognosis of patients with early-stage extranodal NK/T cell lymphoma (nasal type) and its individualized application]J Yang, Y Yang, S N Qi, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2021
[Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type]X D Wang, X Liu, T Wu, et al.Cell|May 14, 2026
A comparison of deep multiomics profiles across ethnicity, geography, and ageNasim Barapour, John Z Cao, Yue Wu, et al.Pageof 52